Utility of Samples in Bacteriological Prospective Series of Ulcers Leg Infected Clinically (ULCERINFECTE)
Primary Purpose
Leg Ulcer
Status
Active
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
a swab according to the method of Levine
Bacteriological referred to biopsy
Sponsored by
About this trial
This is an interventional treatment trial for Leg Ulcer
Eligibility Criteria
Inclusion Criteria:
- Man or woman over 18 years
- Hospitalized for a leg ulcer whatever the etiology, vascular medicine
- Having clinical criteria and / or biological that suggest infection
- No opposition to participate in the study
Exclusion Criteria:
- Arterial ulcers requiring revascularization (digging ulcers, tendon or bone exposure, necrosis, toe pressure <50 mmHg)
- Ulcers cancer
- Ulcers with acute bacterial cellulitis: large painful acute red leg
- Poor understanding of the French language
- Major hearing impairment
- Severe cognitive or psychiatric disorders
Sites / Locations
- Groupe Hospitalier Paris Saint Joseph
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
a swab according to the method of Levine
Bacteriological referred to biopsy
Arm Description
Outcomes
Primary Outcome Measures
Assessment of change of treatment response
Disappearance of at least two signs of infection from the following:
abundant exudate (dry coverage compresses)
local heat
smelly character
50% decrease of erythema ulcerous perished And reduction in pain of at least two points on the digital scale
Assessement of the infection statue by medical examination
The physician will answer on the CRF (Clinical Report Form) by: Yes or no
Secondary Outcome Measures
Assessment of change of the ulcer aspect
Photographs taken on arrival to 48 hours before transplantation where graft and out: proofreading blind to validate a posteriori the clinical criteria
Full Information
NCT ID
NCT02889926
First Posted
August 23, 2016
Last Updated
April 26, 2023
Sponsor
Fondation Hôpital Saint-Joseph
1. Study Identification
Unique Protocol Identification Number
NCT02889926
Brief Title
Utility of Samples in Bacteriological Prospective Series of Ulcers Leg Infected Clinically
Acronym
ULCERINFECTE
Official Title
Utility of Samples in Bacteriological Prospective Series of Ulcers Leg Infected Clinically
Study Type
Interventional
2. Study Status
Record Verification Date
April 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
February 10, 2017 (Actual)
Primary Completion Date
January 18, 2019 (Actual)
Study Completion Date
December 31, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondation Hôpital Saint-Joseph
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Leg ulcers are defined as wounds lasting for more than a month. They would receive 0.2% of the population of Western countries. In Europe, the cost per episode of leg ulcers is estimated at 6650 euros (10 000 euros for a foot ulcer). The cost of treatment of wounds would be 2 to 4% of the health budget. Infection is the most common complication of chronic wounds: in most cases, it results in delayed healing, at most, it can result in amputation or serious general complications Bacterial contamination of ulcers is constant. Over time for over 25 years, various studies have shown about relatively identical results. The bacteria are present in over 90% of the etiology of venous leg ulcers. These bacteria are divided into four most common classes: Staphylococcus aureus, Enterococcus, Streptococcus, Pseudomonas. The bacterial ecology changes over time. Indeed Staphylococcus aureus appears first, while the Pseudomonas is associated with ulcers lasting for several months. Anaerobic more difficult to find, are found in 30% of cases Cohabitation between leg ulcers and bacteria often without clinical consequence: These are the stages of infection and colonization.
The infection is related to the proliferation of bacteria and their invasion into the skin, by increasing their virulence (virulence genes acquisition). The increase in the number of bacteria and the multiplicity of bacterial genera are one reason for the increased virulence of bacteria. When bacteria proliferate, because the host defenses are inadequate, or because there is a vascular disease which promotes the proliferation, clinical signs appear
Detailed Description
RESEARCH PROJECT Vascular medicine at St Joseph, the management of chronic wounds concerns 80% of hospitalized patients, more than 1,000 patients per year. The reason for hospitalization of these patients outside of revascularization gestures, often performing a skin graft. The existence of an infection of the ulcer on arrival in the service is not a cons-indication for transplant, but will delay it until the signs of infection are brought under control. This scenario is common. The Medical Information department on six months, noted over 100 patients coded "leg ulcers" principal diagnosis and "soft tissue infections" secondary diagnosis.
The importance of this recruitment and the lack of recommendations for the management of these patients justifies the completion of a clinical and microbiological work Until recent months, at the request of Microbiology, bacteriological referred to biopsy was performed first line when suspected of being infected ulcer. After reading the literature, and because of the invasive nature of this gesture, the evaluation of biopsy compared to the swab in a large patient population seems to necessary to the investigators
The proposed work is randomized blinded for microbiological and observational part for the clinical part, on a prospective series of consecutive carriers of infected leg ulcer patients, regardless of the etiology of leg ulcers, excluding dermohypodermitis complicating acute bacterial leg ulcers, with several objectives:
PRIMARY OBJECTIVE Demonstrate the non-inferiority of the swab compared to biopsy in the management of patients hospitalized for infected leg ulcer
two situations
If graft Primary endpoint: time in days between the beginning of hospitalization and the day the transplant can be performed. Indeed, the transplants are performed when the doctor determines that the infection is under control
If the patient is not grafted:
Primary endpoint: time between the beginning of hospitalization and the end of the ideal hospitalization (when the clinician believes that the patient can get out)
SECONDARY OBJECTIVES and CRITERIA healing rate of patients at 1 month, 3 months and 6 months bacteriological agreement: between the swab and biopsy Comparing the interest of biopsy compared to the swab: percentage of patients for whom the unblinding was necessary and where the biopsy was more informative than the swab (different bacteria require special treatment) .
levies failure rate when the sample is sterile while the ulcer is infected clinically. The collection of demographic, etiological, nutritional profile, and the collection of various local signs can provide indicators of response to the proposed strategy. This type of study has never been done in the population of leg ulcers.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Leg Ulcer
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
100 (Actual)
8. Arms, Groups, and Interventions
Arm Title
a swab according to the method of Levine
Arm Type
Experimental
Arm Title
Bacteriological referred to biopsy
Arm Type
Experimental
Intervention Type
Biological
Intervention Name(s)
a swab according to the method of Levine
Intervention Description
A swab according to the method of Levine: choose the pathological area by pressing the swab over the area, with a rotation supported on at least 1 cm² for 5 seconds, to well up from the liquid.
Intervention Type
Biological
Intervention Name(s)
Bacteriological referred to biopsy
Intervention Description
Bacteriological referred to biopsy: (This is the hole protocol) Choose the pathological area, debridement of the wound to the pad and a scalpel, cleaning with betadine followed by rinsing with saline, local anesthesia with xylocaine, 6 mm punch for drawing a carrot, put into a sterile container
Primary Outcome Measure Information:
Title
Assessment of change of treatment response
Description
Disappearance of at least two signs of infection from the following:
abundant exudate (dry coverage compresses)
local heat
smelly character
50% decrease of erythema ulcerous perished And reduction in pain of at least two points on the digital scale
Time Frame
Hour 24 and hour 72
Title
Assessement of the infection statue by medical examination
Description
The physician will answer on the CRF (Clinical Report Form) by: Yes or no
Time Frame
Day-1 and the Day 1 after release
Secondary Outcome Measure Information:
Title
Assessment of change of the ulcer aspect
Description
Photographs taken on arrival to 48 hours before transplantation where graft and out: proofreading blind to validate a posteriori the clinical criteria
Time Frame
At Hour 0 and Hour 48
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Man or woman over 18 years
Hospitalized for a leg ulcer whatever the etiology, vascular medicine
Having clinical criteria and / or biological that suggest infection
No opposition to participate in the study
Exclusion Criteria:
Arterial ulcers requiring revascularization (digging ulcers, tendon or bone exposure, necrosis, toe pressure <50 mmHg)
Ulcers cancer
Ulcers with acute bacterial cellulitis: large painful acute red leg
Poor understanding of the French language
Major hearing impairment
Severe cognitive or psychiatric disorders
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Isabelle LAZARETH, MD
Organizational Affiliation
Fondation Hôpital Saint-Joseph
Official's Role
Principal Investigator
Facility Information:
Facility Name
Groupe Hospitalier Paris Saint Joseph
City
Paris
State/Province
Ile-de-France
ZIP/Postal Code
75014
Country
France
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Utility of Samples in Bacteriological Prospective Series of Ulcers Leg Infected Clinically
We'll reach out to this number within 24 hrs